In this edition:
Future treatments for Pompe disease
ALS/FTD genetics landscape
Emerging phenotype in infantile Pompe disease
Serum biomarkers in myotonic dystrophy type 1
Muscle biopsies in the era of NGS
Genomics and DNA methylation in diabetic neuropathy
Anti-HMGCR necrotising myopathy
New avenues in diagnostics and research of neuromuscular diseases
GBS & COVID-19 infections and vaccination
Treatment of GBS
Please login below to download this issue (PDF)